Last reviewed 2026-04-20 · How we verify

Proventil 180 μg

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Nasopharyngitis
• COVID-19
• Upper respiratory tract infection
• Headache
• Bronchitis
• Sinusitis
• Cough
• Back pain
• Hypertension
• Influenza
• Dysphonia
• Diarrhoea

Key clinical trials

• A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma (PHASE3)
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (PHASE3)
• A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma (PHASE3)
• A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma (PHASE3)
• Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants. (PHASE1)
• A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma (PHASE3)
• A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma (PHASE3)
• A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.